Skip to main content
CreoSG Co.,Ltd. logo

CreoSG Co.,Ltd. — Investor Relations & Filings

Ticker · 040350 ISIN · KR7040350001 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 355 across all filing types
Latest filing 2019-02-11 Management Reports
Country KR South Korea
Listing KO 040350

About CreoSG Co.,Ltd.

https://www.creosg.com/

CreoSG Co., Ltd. is a company with two primary business divisions: IT solutions and biotechnology. The IT solutions division specializes in providing services to financial institutions, focusing on the development and implementation of next-generation systems, application development, and IT outsourcing. The biotechnology division is dedicated to the research and development of vaccines. Its main pipeline includes an HIV/AIDS vaccine candidate and a COVID-19 vaccine. The company's vaccine development is based on its proprietary recombinant Vesicular Stomatitis Virus (VSV) vector system, which serves as its core technological platform.

Recent filings

Filing Released Lang Actions
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports Classification · 95% confidence The document is a regulatory filing from a Korean company (Curocom) announcing a significant change in financial results (revenue or profit/loss structure exceeding 15% for large corporations). This is a standard regulatory disclosure requirement in the Korean market (DART system) for reporting preliminary financial performance before the final audit is completed. Since it provides key financial highlights and explanations for the changes, it fits best as an Earnings Release (ER) as it serves as the initial announcement of financial results.
2019-02-11 Korean
타인에대한채무보증결정
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory filing regarding a 'Decision on Debt Guarantee for Others' (타인에 대한 채무보증결정) by Curocom. It details the financial terms, the debtor (GNCO), the board resolution date, and the impact on the company's capital structure. As this is a specific regulatory disclosure required by the Capital Markets Act in Korea regarding financial guarantees, it falls under the 'Regulatory Filings' category as it does not fit into specific categories like M&A, Dividends, or Share Issues.
2019-01-28 Korean
전환사채(해외전환사채포함)발행후만기전사채취득(제13회차)
Capital/Financing Update Classification · 95% confidence The document is a regulatory filing from the Korean Exchange (KRX) regarding the acquisition of convertible bonds before maturity by the issuer (Curocom). It details the specific bond series, acquisition amount, reason (early redemption request), and future handling of the bonds. This falls under capital structure changes and financing updates, specifically related to debt instruments.
2019-01-04 Korean
전환가액의조정(제13회차)
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system regarding the adjustment of the conversion price for convertible bonds (13th series). It details the change in conversion price, the number of convertible shares, and the underlying calculation methodology due to a decline in market price. This type of disclosure regarding capital structure and debt instrument terms falls under 'Capital/Financing Update'.
2019-01-04 Korean
주주명부폐쇄기간또는기준일설정
Share Issue/Capital Change Classification · 95% confidence The document is a short regulatory notice regarding the suspension of share registration (closing of the shareholder register) for the purpose of determining shareholders eligible to vote at the upcoming Annual General Meeting. It does not contain the full report or proxy materials, but rather serves as a formal regulatory announcement of a corporate action. Given it does not fit into specific categories like dividend announcements or share buybacks, it falls under the general regulatory filing category.
2018-12-14 Korean
전환가액의조정(제16회차)
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price for convertible bonds (CB) issued by the company. It details the change in conversion price, the number of convertible shares, and the underlying calculation methodology based on market price fluctuations. This falls under capital structure changes and financing updates, specifically related to convertible debt instruments.
2018-12-06 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.